Next Article in Journal
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Next Article in Special Issue
Formulation and Evaluation of Polymeric Spherical Agglomerates-Based Porous Orodispersible Tablets of Cilnidipine
Previous Article in Journal
Molecular Docking and Antihypertensive Activity of Eupalitin 3-O-β-D-galactopyranoside Isolated from Boerhavia diffusa Linn
Previous Article in Special Issue
Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1630; https://doi.org/10.3390/pharmaceutics16121630
Action Date Notes Link
article xml file uploaded 23 December 2024 10:19 CET Original file -
article xml uploaded. 23 December 2024 10:19 CET Update https://www.mdpi.com/1999-4923/16/12/1630/xml
article pdf uploaded. 23 December 2024 10:19 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1630/pdf
article html file updated 23 December 2024 10:21 CET Original file https://www.mdpi.com/1999-4923/16/12/1630/html
Back to TopTop